HM-3030

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameHM-3030
Drug Alias Namebeta lactamase inhibitor (Hanmi)HM-3030
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta Lactamase inhibitors
TargetsBeta Lactamase
Therapy Area/IndicationsMultidrug-Resistant Infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHanmi Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsMultidrug-Resistant Infection

Other Information

ATC CodeN/A
Related LinksN/A